Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06895148 · ClinicalTrials.gov registry record · NA
ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation
A NA study of Ventilation, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 1,125
- Enrollment target
- 1
- Study location
NCT06895148: Recruiting NA study of Ventilation, sponsored by University of Minnesota.
NCT06895148 is a NA study of Ventilation that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 1,125 participants, above the 256-participant average among 4 other Ventilation trials with a reported enrollment target (339% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06895148, a NA study of Ventilation, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,125 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a cluster randomized trial across 10 hospitals, stratified by hospital size (hospitals with greater than 100 mechanically ventilated patients a year will be classified as large, while those with 100 or fewer will be classified as small). Randomization will occur at the hospital level, ensuring an even distribution of large and small hospitals between study arms. Hospitals assigned to the intervention group will implement an EHR-based strategy designed to enhance adherence to lung-protective ventilation (LPV) for a 9-month intervention period, after which the strategy will be rolled out to all hospitals. The intervention focuses on modifying the ventilator order within the Electronic Health Record (EHR) to encourage default settings aligned with LPV principles. This study design allows for comparison of patient outcomes before and after implementation within each hospital while also enabling simultaneous comparisons between hospitals that have and have not yet received the intervention. The cluster randomization approach is necessary, given the order is controlled at the hospital level.
Primary Outcome
The primary outcome is a binary indicator of lung-protective ventilation (ventilator set at ≤ 8 cc/kg) at the first documented set tidal volume after 4 hours.
Conditions Studied
Interventions
- DEVICE New ventilator
- DEVICE control ventilator
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,125 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-07-16 |
| Phase | NA |
What NCT06895148 shows while recruiting
NCT06895148 is an interventional study that assigns participants to a tested intervention. Its 1,125 participants enrollment target places it among the larger protocols in the corpus, above the 256-participant average among 4 other Ventilation trials with a reported enrollment target (339% higher).
The record links to 1 condition, with Ventilation appearing as the primary indexed condition, and to 2 interventions - of which New ventilator is the first listed.
NCT06895148 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06895148 about?
NCT06895148 is a clinical study titled "ADHERE-LPV Advancing Delivery of High-Quality Evidence-Based Respiratory Efforts in Lung-Protective Ventilation". This study is a cluster randomized trial across 10 hospitals, stratified by hospital size (hospitals with greater than 100 mechanically ventilated patients a year will be classified as large, while those with 100 or fewer will be classified as small). Randomization will occur at the hospital level, ...
What is the current status of trial NCT06895148?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,125 participants. The study started on 2025-07-01. Estimated completion is 2026-07-16.
What conditions does trial NCT06895148 study?
This clinical trial studies the following conditions: Ventilation.
What interventions are being tested in trial NCT06895148?
The interventions under investigation include: New ventilator (DEVICE), control ventilator (DEVICE).
Who is sponsoring clinical trial NCT06895148?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06895148 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.
RECRUITING · NA
-
Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy
COMPLETED · NA
-
Pilot Evaluation Comparing Regional Distribution of Ventilation During Lung Expansion Therapy
COMPLETED · NA
-
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04421768 · 1,125 participants · NA
Effects of Systematic Cervical Exam Training on Labor and Delivery Care
- NCT06746129 · 1,126 participants · Phase 3
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
- NCT05438329 · 1,123 participants · Phase 1
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
- NCT06952504 · 1,123 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI